Merck KGaA
MKKGY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $21,156 | $20,993 | $22,232 | $19,687 |
| % Growth | 0.8% | -5.6% | 12.9% | – |
| Cost of Goods Sold | $8,671 | $8,600 | $8,527 | $7,351 |
| Gross Profit | $12,485 | $12,393 | $13,705 | $12,336 |
| % Margin | 59% | 59% | 61.6% | 62.7% |
| R&D Expenses | $2,279 | $2,445 | $2,521 | $2,408 |
| G&A Expenses | $1,392 | $1,392 | $1,306 | $1,241 |
| SG&A Expenses | $5,360 | $5,329 | $5,403 | $4,955 |
| Sales & Mktg Exp. | $3,968 | $3,914 | $4,097 | $3,714 |
| Other Operating Expenses | $1,201 | $1,010 | $1,029 | $777 |
| Operating Expenses | $8,840 | $8,784 | $8,953 | $8,140 |
| Operating Income | $3,645 | $3,609 | $4,474 | $4,179 |
| % Margin | 17.2% | 17.2% | 20.1% | 21.2% |
| Other Income/Exp. Net | -$109 | -$125 | -$187 | -$255 |
| Pre-Tax Income | $3,536 | $3,484 | $4,287 | $3,924 |
| Tax Expense | $751 | $650 | $948 | $859 |
| Net Income | $2,777 | $2,824 | $3,326 | $3,055 |
| % Margin | 13.1% | 13.5% | 15% | 15.5% |
| EPS | 1.28 | 1.3 | 1.53 | 1.41 |
| % Growth | -1.5% | -15% | 8.5% | – |
| EPS Diluted | 1.28 | 1.3 | 1.53 | 1.41 |
| Weighted Avg Shares Out | 2,174 | 2,176 | 2,174 | 2,174 |
| Weighted Avg Shares Out Dil | 2,174 | 2,174 | 2,174 | 2,174 |
| Supplemental Information | – | – | – | – |
| Interest Income | $164 | $121 | $73 | $54 |
| Interest Expense | $292 | $272 | $204 | $288 |
| Depreciation & Amortization | $2,134 | $1,880 | $1,798 | $1,712 |
| EBITDA | $5,962 | $5,685 | $6,279 | $5,880 |
| % Margin | 28.2% | 27.1% | 28.2% | 29.9% |